210 related articles for article (PubMed ID: 35458609)
1. Distinct Mechanisms of Cytotoxicity in Novel Nitrogenous Heterocycles: Future Directions for a New Anti-Cancer Agent.
Suliman RS; Alghamdi SS; Ali R; Rahman I; Alqahtani T; Frah IK; Aljatli DA; Huwaizi S; Algheribe S; Alehaideb Z; Islam I
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458609
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
4. Novel Anti-Tubulin Compounds from
Alghamdi SS; Suliman RS; Alsaeed AS; Almutairi KK; Aljammaz NA; Altolayyan A; Ali R; Alhallaj A
Drug Des Devel Ther; 2021; 15():4195-4211. PubMed ID: 34675483
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors.
Sana S; Tokala R; Bajaj DM; Nagesh N; Bokara KK; Kiranmai G; Lakshmi UJ; Vadlamani S; Talla V; Shankaraiah N
Bioorg Chem; 2019 Dec; 93():103317. PubMed ID: 31586714
[TBL] [Abstract][Full Text] [Related]
6. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
[TBL] [Abstract][Full Text] [Related]
8. Anti-proliferative potential of triphenyl substituted pyrimidines against MDA-MB-231, HCT-116 and HT-29 cancer cell lines.
Ranjan Dwivedi A; Kumar V; Kaur H; Kumar N; Prakash Yadav R; Poduri R; Baranwal S; Kumar V
Bioorg Med Chem Lett; 2020 Oct; 30(20):127468. PubMed ID: 32768647
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of Novel Dihydropyrimidinone Derivatives as Potential Anticancer Agents and Tubulin Polymerization Inhibitors.
Rawal R; Gupta PK; Kumar B; Bhatia R
Assay Drug Dev Technol; 2023 Jan; 21(1):17-28. PubMed ID: 36594970
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of N-acyl Derivatives of Aminocombretastatin A-4 and Study of their Interaction with Tubulin and Downregulation of c-Myc.
Agut R; Falomir E; Murga J; Martín-Beltrán C; Gil-Edo R; Pla A; Carda M; Díaz JF; Josa-Prado F; Marco JA
Med Chem; 2021; 17(10):1129-1139. PubMed ID: 33222678
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
14. Discovery, biological evaluation, structure-activity relationships and mechanism of action of pyrazolo[3,4-b]pyridin-6-one derivatives as a new class of anticancer agents.
Guo Q; Luo Y; Zhai S; Jiang Z; Zhao C; Xu J; Wang L
Org Biomol Chem; 2019 Jun; 17(25):6201-6214. PubMed ID: 31179474
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY
Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-
Goel KK; Hussain A; Altamimi MA; Rajput SK; Sharma PP; Kharb R; Mahdi WA; Imam SS; Alshehri S; Alnemer OA; Chaudhary A
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677860
[TBL] [Abstract][Full Text] [Related]
17. New thiazole-2(3H)-thiones containing 4-(3,4,5-trimethoxyphenyl) moiety as anticancer agents.
Ansari M; Shokrzadeh M; Karima S; Rajaei S; Fallah M; Ghassemi-Barghi N; Ghasemian M; Emami S
Eur J Med Chem; 2020 Jan; 185():111784. PubMed ID: 31669850
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors.
Liang T; Zhou X; Lu L; Dong H; Zhang Y; Xu Y; Qi J; Zhang Y; Wang J
Bioorg Chem; 2021 May; 110():104793. PubMed ID: 33770673
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Molecular Docking, and Biological Evaluation of 2,3-Diphenylquinoxaline Derivatives as a Tubulin's Colchicine Binding Site Inhibitor Based on Primary Virtual Screening.
Rezaei Z; Asadi M; Montazer MN; Rezaeiamiri E; Bahadorikhalili S; Amini M; Amanlou M
Anticancer Agents Med Chem; 2022; 22(10):2011-2025. PubMed ID: 34702157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
